TP53 and cancer: p53 loss leads to high expression of the Golgi scaffold PAQR11 and enhances the secretion of protease urokinase plasminogen activator (PLAU), which activates autocrine signals that accelerate secretory vesicle biogenesis in the Golgi, completing a prosecretory feed-forward loop in p53-deficient cancer cells (4).